DDrare: Database of Drug Development for Rare Diseases

Pasireotide 0.6 mg/ml (DrugBank: Pasireotide)

3 diseases

ID	Disease name (Link within this page)	Number of trials
67	Polycystic kidney disease	0
74	Prolactin secreting pituitary adenoma	0
75	Cushing disease	1

67. Polycystic kidney disease [ 186 clinical trials, 196 drugs, (DrugBank: 47 drugs), 35 drug target genes, 146 drug target pathways]

Searched query = "Polycystic kidney disease", "PKD", "PCKD", "Polycystic kidney", "ADPKD", "ARPKD"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 186 trial found

74. Prolactin secreting pituitary adenoma [ 18 clinical trials, 33 drugs, (DrugBank: 10 drugs), 16 drug target genes, 63 drug target pathways]

Searched query = "Prolactin secreting pituitary adenoma", "Pituitary PRL secretion hyperthyroidism", "Prolactinoma", "Prolactin secreting adenoma"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 18 trial found

75. Cushing disease [ 191 clinical trials, 172 drugs, (DrugBank: 48 drugs), 61 drug target genes, 121 drug target pathways]

Searched query = "Cushing disease", "Cushing"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 191 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03080181 (ClinicalTrials.gov)	May 2013	3/3/2017	Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment	Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment: Correlation With Disease Activity, Insulin Sensitivity and Secretion Parameters	Cushing Disease	Drug: Pasireotide 0.6 MG/ML	University of Palermo	NULL	Completed	18 Years	N/A	All	24	Phase 4	NULL